Literature DB >> 33475868

German tariffs for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluations at the end of life.

Judith Dams1, Elisabeth Huynh2, Steffi Riedel-Heller3, Margrit Löbner3, Christian Brettschneider4, Hans-Helmut König4.   

Abstract

OBJECTIVES: Economic evaluations often use preference-based value sets (tariffs) for health-related quality of life to quantify health effects. For wellbeing at the end of life, issues beyond health-related quality of life may be important. Therefore, the ICECAP Supportive Care Measure (ICECAP-SCM), based on the capability approach, was developed. A validated German ICECAP-SCM version was published recently. However, tariffs for the German ICECAP-SCM are not available. Therefore, the aim was to determine tariffs for the ICECAP-SCM based on preferences of the German general population.
METHODS: An online sample of 2996 participants completed a best-worst scaling (BWS) and a discrete choice experiment (DCE). BWSs required participants to choose the best and worst statement within the same capability state, whereas DCEs required participants to trade-off between two capability states. First, BWS and DCE data were analyzed separately. Subsequently, combined data were analyzed using scale-adjusted conditional logit latent class models. Models were selected based on the stability of solutions and the Bayesian information criterion.
RESULTS: The two latent class model was identified to be optimal for the BWS, DCE, and combined data, and was used to derive tariffs for the ICECAP-SCM capability states. BWS data captured differences in ICECAP-SCM scale levels, whereas DCE data additionally explained interactions between the seven ICECAP-SCM attributes. DISCUSSION: The German ICECAP-SCM tariffs can be used in addition to health-related quality of life to quantify effectiveness in economic evaluations. The tariffs based on BWS data were similar for Germany and the UK, whereas the tariffs based on combined data varied. We would recommend to use tariffs based on combined data in German evaluations. However, only results on BWS data are comparable between Germany and the UK, so that tariffs based on BWS data should be used when comparing results between Germany and the UK.

Entities:  

Keywords:  Best–worst scaling; Capability; Discrete choice experiment; End-of-life; ICECAP-SCM; Value set

Year:  2021        PMID: 33475868     DOI: 10.1007/s10198-020-01260-2

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  17 in total

Review 1.  A systematic review of measures of end-of-life care and its outcomes.

Authors:  Richard A Mularski; Sydney M Dy; Lisa R Shugarman; Anne M Wilkinson; Joanne Lynn; Paul G Shekelle; Sally C Morton; Virginia C Sun; Ronda G Hughes; Lara K Hilton; Margaret Maglione; Shannon L Rhodes; Cony Rolon; Karl A Lorenz
Journal:  Health Serv Res       Date:  2007-10       Impact factor: 3.402

2.  Valuing the ICECAP capability index for older people.

Authors:  Joanna Coast; Terry N Flynn; Lucy Natarajan; Kerry Sproston; Jane Lewis; Jordan J Louviere; Tim J Peters
Journal:  Soc Sci Med       Date:  2008-06-21       Impact factor: 4.634

3.  In search of a good death: observations of patients, families, and providers.

Authors:  K E Steinhauser; E C Clipp; M McNeilly; N A Christakis; L M McIntyre; J A Tulsky
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

4.  Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

Authors:  Melanie Calvert; Derek Kyte; Rebecca Mercieca-Bebber; Anita Slade; An-Wen Chan; Madeleine T King; Amanda Hunn; Andrew Bottomley; Antoine Regnault; An-Wen Chan; Carolyn Ells; Daniel O'Connor; Dennis Revicki; Donald Patrick; Doug Altman; Ethan Basch; Galina Velikova; Gary Price; Heather Draper; Jane Blazeby; Jane Scott; Joanna Coast; Josephine Norquist; Julia Brown; Kirstie Haywood; Laura Lee Johnson; Lisa Campbell; Lori Frank; Maria von Hildebrand; Michael Brundage; Michael Palmer; Paul Kluetz; Richard Stephens; Robert M Golub; Sandra Mitchell; Trish Groves
Journal:  JAMA       Date:  2018-02-06       Impact factor: 56.272

5.  Quality end-of-life care: patients' perspectives.

Authors:  P A Singer; D K Martin; M Kelner
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272

6.  Quality of Life in Palliative Care.

Authors:  Mellar P Davis; David Hui
Journal:  Expert Rev Qual Life Cancer Care       Date:  2017-11-08

7.  Strategies for the economic evaluation of end-of-life care: making a case for the capability approach.

Authors:  Joanna Coast
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2014-05-02       Impact factor: 2.217

Review 8.  Patient reported outcome measures for measuring dignity in palliative and end of life care: a scoping review.

Authors:  Bridget Johnston; Kate Flemming; Melanie Jay Narayanasamy; Carolyn Coole; Beth Hardy
Journal:  BMC Health Serv Res       Date:  2017-08-22       Impact factor: 2.655

9.  Development of a supportive care measure for economic evaluation of end-of-life care using qualitative methods.

Authors:  Eileen J Sutton; Joanna Coast
Journal:  Palliat Med       Date:  2013-05-22       Impact factor: 4.762

10.  An analysis of the complementarity of ICECAP-A and EQ-5D-3 L in an adult population of patients with knee pain.

Authors:  T Keeley; J Coast; E Nicholls; N E Foster; S Jowett; H Al-Janabi
Journal:  Health Qual Life Outcomes       Date:  2016-03-03       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.